Skip to main content
Clinical Trials/CTRI/2023/01/048659
CTRI/2023/01/048659
Completed
Phase 3

Injectable liquid Platelet Rich Fibrin (iPRF) as a vehicle for local drug delivery (LDD) in periodontal therapy - A Randomised Controlled clinical Trial

Thamaraiselvan Murugan0 sites79 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: K053- Chronic periodontitis
Sponsor
Thamaraiselvan Murugan
Enrollment
79
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
March 18, 2023
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Thamaraiselvan Murugan

Eligibility Criteria

Inclusion Criteria

  • Patient selection was done according to the 2017 World Work­ shop on the Classification of Periodontal and Peri­Implant Diseases and Conditions. Patients with Stage II Grade B peri­odontitis (moderate periodontitis) were included. Patients having a minimum of 2 sites with probing depth (PD) \> 5 mm and clinical attachment loss (CAL) \>4 mm with horizontal bone loss at 2 different quadrants, and requiring non­surgical treat­ment were considered as eligible for the study.

Exclusion Criteria

  • Patients with habits, like smoking, tobacco chewing or alcohol consumption, having uncontrolled diabetes, hyper­ tension or immunocompromised conditions, pregnant women or lactating mothers, non­compliant or physically challenged people, and those who were not able to main­ tain oral hygiene or be followed up at a recall visit

Outcomes

Primary Outcomes

Not specified

Similar Trials